Stereotactic body radiotherapy for primary prostate cancer: A systematic review

Journal of Medical Imaging and Radiation Oncology

Volumn 58, Issue 5, 2014, Pages 601-611

  Tan, Tze Jian ^a   Siva, Shankar ^a,b   Foroudi, Farshad ^a   Gill, Suki ^a  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Prostate cancer; Radiation oncology; Review; Stereotactic radiotherapy

Indexed keywords

ACUTE TOXICITY; BIOCHEMICAL RECURRENCE FREE SURVIVAL; CANCER RADIOTHERAPY; CANCER SURVIVAL; COST EFFECTIVENESS ANALYSIS; CYBERKNIFE; FOLLOW UP; GASTROINTESTINAL TOXICITY; HUMAN; MALE; NEPHROTOXICITY; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PROGRESSION FREE SURVIVAL; PROSTATE CANCER; QUALITY OF LIFE; RADIATION DOSE FRACTIONATION; RETROSPECTIVE STUDY; REVIEW; STEREOTACTIC BODY RADIATION THERAPY; SYSTEMATIC REVIEW; ADULT; AGED; ECONOMICS; EVIDENCE BASED MEDICINE; HEALTH CARE COST; MIDDLE AGED; MORTALITY; PROSTATIC NEOPLASMS; RADIATION INJURY; RADIOSURGERY; RECTUM DISEASE; RISK FACTOR; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; DOSE FRACTIONATION; EVIDENCE-BASED MEDICINE; HEALTH CARE COSTS; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; RADIATION INJURIES; RADIOSURGERY; RECTAL DISEASES; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84907899927     PISSN: 17549477     EISSN: 17549485     Source Type: Journal    
DOI: 10.1111/1754-9485.12213     Document Type: Review

References (44)

1. Kupelian PA, Potters L, Khuntia D et al. Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy > or = 72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer. Int J Radiat Oncol Biol Phys 2004; 58: 25-33.
2. Trinh QD, Schmitges J, Sun M et al. Open radical prostatectomy in the elderly: a case for concern? BJU Int 2012; 109: 1335-40.
3. Collins CD, Lloyd-Davies RW, Swan AV. Radical external beam radiotherapy for localised carcinoma of the prostate using a hypofractionation technique. Clin Oncol (R Coll Radiol) 1991; 3: 127-32.
4. Sahgal A, Roberge D, Schellenberg D et al. The Canadian Association of Radiation Oncology scope of practice guidelines for lung, liver and spine stereotactic body radiotherapy. Clin Oncol (R Coll Radiol) 2012; 24: 629-39.
5. Brenner DJ, Hall EJ. Fractionation and protraction for radiotherapy of prostate carcinoma. Int J Radiat Oncol Biol Phys 1999; 43: 1095-101.
6. Duchesne GM, Peters LJ. What is the alpha/beta ratio for prostate cancer? Rationale for hypofractionated high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys 1999; 44: 747-8.
7. Bentzen SM, Ritter MA. The alpha/beta ratio for prostate cancer: what is it, really? Radiother Oncol 2005; 76: 1-3.
8. Dasu A. Is the alpha/beta value for prostate tumours low enough to be safely used in clinical trials? Clin Oncol (R Coll Radiol) 2007; 19: 289-301.
9. van der Kogel AJ, Jarrett KA, Paciotti MA, Raju MR. Radiation tolerance of the rat rectum to fractionated X-rays and pi-mesons. Radiother Oncol 1988; 12: 225-32.
10. Dewit L, Oussoren Y, Bartelink H, Thames HD. The effect of cis-diamminedichloroplatinum(II) on radiation damage in mouse rectum after fractionated irradiation. Radiother Oncol 1989; 16: 121-8.
11. Brenner D, Armour E, Corry P, Hall E. Sublethal damage repair times for a late-responding tissue relevant to brachytherapy (and external-beam radiotherapy): implications for new brachytherapy protocols. Int J Radiat Oncol Biol Phys 1998; 41: 135-8.
12. Brenner DJ. Fractionation and late rectal toxicity. Int J Radiat Oncol Biol Phys 2004; 60: 1013-15.
13. Fiorino C, Sanguineti G, Valdagni R. Fractionation and late rectal toxicity: no reliable estimates of alpha/beta value for rectum can be derived from studies where different volumes of rectum are irradiated at different dose levels: in regard to Brenner (Int J Radiat Oncol Biol Phys 2004;60:1013-1015.). Int J Radiat Oncol Biol Phys 2005; 62: 289-90. author reply 90-1.
14. Fowler JF, Ritter MA, Chappell RJ, Brenner DJ. What hypofractionated protocols should be tested for prostate cancer? Int J Radiat Oncol Biol Phys 2003; 56: 1093-104.
15. Fuks Z, Kolesnick R. Engaging the vascular component of the tumor response. Cancer Cell 2005; 8: 89-91.
16. Liberati A, Altman DG, Tetzlaff J et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 2009; 6: e1000100.
17. King CR, Freeman D, Kaplan I et al. Stereotactic body radiotherapy for localized prostate cancer: pooled analysis from a multi-institutional consortium of prospective phase II trials. Radiother Oncol 2013; 109: 217-21.
18. Fuller DB, Naitoh J, Lee C, Hardy S, Jin H. Virtual HDR CyberKnife treatment for localized prostatic carcinoma: dosimetry comparison with HDR brachytherapy and preliminary clinical observations. Int J Radiat Oncol Biol Phys 2008; 70: 1588-97.
19. Madsen BL, Hsi RA, Pham HT, Fowler JF, Esagui L, Corman J. Stereotactic hypofractionated accurate radiotherapy of the prostate (SHARP), 33.5 Gy in five fractions for localized disease: first clinical trial results. Int J Radiat Oncol Biol Phys 2007; 67: 1099-105.
20. Friedland JL, Freeman DE, Masterson-McGary ME, Spellberg DM. Stereotactic body radiotherapy: an emerging treatment approach for localized prostate cancer. Technol Cancer Res Treat 2009; 8: 387-92.
21. Katz AJ, Santoro M, Ashley R, Diblasio F, Witten M. Stereotactic body radiotherapy for organ-confined prostate cancer. BMC Urol 2010; 10: 1.
22. Bolzicco G, Favretto MS, Scremin E, Tambone C, Tasca A, Guglielmi R. Image-guided stereotactic body radiation therapy for clinically localized prostate cancer: preliminary clinical results. Technol Cancer Res Treat 2010; 9: 473-7.
23. King CR, Brooks JD, Gill H, Presti JC Jr. Long-term outcomes from a prospective trial of stereotactic body radiotherapy for low-risk prostate cancer. Int J Radiat Oncol Biol Phys 2012; 82: 877-82.
24. McBride SM, Wong DS, Dombrowski JJ et al. Hypofractionated stereotactic body radiotherapy in low-risk prostate adenocarcinoma: preliminary results of a multi-institutional phase 1 feasibility trial. Cancer 2012; 118: 3681-90.
25. Loblaw A, Cheung P, D'Alimonte L et al. Prostate stereotactic ablative body radiotherapy using a standard linear accelerator: toxicity, biochemical, and pathological outcomes. Radiother Oncol 2013; 107: 153-8.
26. Boike TP, Lotan Y, Cho LC et al. Phase I dose-escalation study of stereotactic body radiation therapy for low- and intermediate-risk prostate cancer. J Clin Oncol 2011; 29: 2020-6.
27. Jabbari S, Weinberg VK, Kaprealian T et al. Stereotactic body radiotherapy as monotherapy or post-external beam radiotherapy boost for prostate cancer: technique, early toxicity, and PSA response. Int J Radiat Oncol Biol Phys 2012; 82: 228-34.
28. Alongi F, Cozzi L, Arcangeli S et al. Linac based SBRT for prostate cancer in 5 fractions with VMAT and flattening filter free beams: preliminary report of a phase II study. Radiat Oncol 2013; 8: 171.
29. Kang JK, Cho CK, Choi CW et al. Image-guided stereotactic body radiation therapy for localized prostate cancer. Tumori 2011; 97: 43-8.
30. Lee YH, Son SH, Yoon SC et al. Stereotactic body radiotherapy for prostate cancer: a preliminary report. Asia Pac J Clin Oncol 2014; 10: e46-53.
31. Oliai C, Lanciano R, Sprandio B et al. Stereotactic body radiation therapy for the primary treatment of localized prostate cancer. J Radiat Oncol 2013; 2: 63-70.
32. Chen LN, Suy S, Uhm S et al. Stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experience. Radiat Oncol 2013; 8: 58.
33. Katz AJ, Santoro M, Diblasio F, Ashley R. Stereotactic body radiotherapy for localized prostate cancer: disease control and quality of life at 6 years. Radiat Oncol 2013; 8: 118.
34. Smeenk RJ, Teh BS, Butler EB, van Lin EN, Kaanders JH. Is there a role for endorectal balloons in prostate radiotherapy? A systematic review. Radiother Oncol 2010; 95: 277-82.
35. Jones BL, Gan G, Diot Q, Kavanagh B, Timmerman RD, Miften M. Dosimetric and deformation effects of image-guided interventions during stereotactic body radiation therapy of the prostate using an endorectal balloon. Med Phys 2012; 39: 3080-8.
36. Bolzicco G, Favretto MS, Satariano N, Scremin E, Tambone C, Tasca A. A single-center study of 100 consecutive patients with localized prostate cancer treated with stereotactic body radiotherapy. BMC Urol 2013; 13: 49.
37. Katz A, Ferrer M, Suarez JF. Comparison of quality of life after stereotactic body radiotherapy and surgery for early-stage prostate cancer. Radiat Oncol 2012; 7: 194.
38. King CR, Collins S, Fuller D et al. Health-related quality of life after stereotactic body radiation therapy for localized prostate cancer: results from a multi-institutional consortium of prospective trials. Int J Radiat Oncol Biol Phys 2013; 87: 939-45.
39. Hodges JC, Lotan Y, Boike TP, Benton R, Barrier A, Timmerman RD. Cost-effectiveness analysis of stereotactic body radiation therapy versus intensity-modulated radiation therapy: an emerging initial radiation treatment option for organ-confined prostate cancer. J Oncol Pract 2012; 8 (3 Suppl): e31s-7s.
40. Konski A, Watkins-Bruner D, Feigenberg S et al. Using decision analysis to determine the cost-effectiveness of intensity-modulated radiation therapy in the treatment of intermediate risk prostate cancer. Int J Radiat Oncol Biol Phys 2006; 66: 408-15.
41. Sher DJ, Parikh R, Mays-Jackson S, Punglia RS. Cost-effectiveness analysis of SBRT versus IMRT for low-risk prostate cancer. Am J Clin Oncol 2012. [Epub ahead of Print].
42. Parthan A, Pruttivarasin N, Davies D et al. Comparative cost-effectiveness of stereotactic body radiation therapy versus intensity-modulated and proton radiation therapy for localized prostate cancer. Front Oncol 2012; 2: 81.
43. Langen KM, Willoughby TR, Meeks SL et al. Observations on real-time prostate gland motion using electromagnetic tracking. Int J Radiat Oncol Biol Phys 2008; 71: 1084-90.
44. Kilby W, Dooley JR, Kuduvalli G, Sayeh S, Maurer CR Jr. The CyberKnife Robotic Radiosurgery System in 2010. Technol Cancer Res Treat 2010; 9: 433-52.